3 Drug Stocks Hitting 52-Week Highs: Are They Buys?
October has often been a scary month for stocks. That isn't the case so far this year, though. And it's especially not true for three drug stocks.
Biogen (NASDAQ: BIIB), Halozyme Therapeutics (NASDAQ: HALO), and Ionis Pharmaceuticals (NASDAQ: IONS) stocks have all recently hit 52-week highs. What's driving these drug stocks -- and are they still smart picks for long-term investors?
Image source: Getty Images.
Source: Fool.com
Bristol-Myers Squibb Stock
€46.46
11.400%
We see a rather positive sentiment for Bristol-Myers Squibb with 8 Buy predictions and 2 Sell predictions.
With a target price of 70 € there is a hugely positive potential of 50.67% for Bristol-Myers Squibb compared to the current price of 46.46 €.
